N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works

Psychedelics

Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762 · see citing works

Predicting new molecular targets for known drugs

Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667 · see citing works

Hallucinogens

Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211 · see citing works

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · see citing works

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · see citing works

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · see citing works

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B. K., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,119 · see citing works

Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior

González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · see citing works

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859 · see citing works

Serotonin and brain function: a tale of two receptors

Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · see citing works

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690 · see citing works

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583 · see citing works

The Hallucinogen <i>N,N</i> -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator

Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535 · see citing works

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488 · see citing works

Schizophrenia: A New Approach

Osmond, H., & Smythies, J. (1952) · Journal of Mental Science · doi:10.1192/bjp.98.411.309 · Cited by 474 · see citing works

The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience

O’Donovan, K. J., Tourtellotte, W. G., Milbrandt, J., & Baraban, J. M. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01343-5 · Cited by 457 · see citing works

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · see citing works

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

Halberstadt, A. L., & Geyer, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.017 · Cited by 416 · see citing works

Enhanced repertoire of brain dynamical states during the psychedelic experience

Tagliazucchi, E., Carhart-Harris, R. L., Leech, R., Nutt, D., & Chialvo, D. R. (2014) · Human Brain Mapping · doi:10.1002/hbm.22562 · Cited by 399 · see citing works

Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390 · see citing works

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

McKenna, D. J. (2004) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2004.03.002 · Cited by 321 · see citing works

Pharmacokinetics of Hoasca alkaloids in healthy humans

Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., Andrade, E. O., Andrade, E. O., & Mash, D. C. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00168-8 · Cited by 318 · see citing works

Psychedelics and the Human Receptorome

Ray, T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009019 · Cited by 300 · see citing works

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F. D., Bastos, M. D. L., de Pinho, P. G., & Carvalho, M. C. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1513-x · Cited by 292 · see citing works

Dose-Response Study of N,N-Dimethyltryptamine in Humans

Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020009001 · Cited by 291 · see citing works

The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain

Nagai, F., Nonaka, R., & Satoh Hisashi Kamimura, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.075 · Cited by 279 · see citing works

Neuropharmacology of N,N-dimethyltryptamine

Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268 · see citing works

Human psychopharmacology of N,N-dimethyltryptamine

Strassman, R. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00081-2 · Cited by 261 · see citing works

The sigma-1 receptor: roles in neuronal plasticity and disease

Kourrich, S., Su, T.-P., Fujimoto, M., & Bonci, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.09.007 · Cited by 245 · see citing works

The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain

Burchett, S. A., & Hicks, T. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.003 · Cited by 218 · see citing works

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.

Bouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., & Riba, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.008 · Cited by 218 · see citing works

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members

SANTOS, R. G. D., Landeira-Fernández, J., Strassman, R. J., Motta, V., & Cruz, A. P. D. M. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.04.012 · Cited by 205 · see citing works

Dimethyltryptamin: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism

Szára, S. (1956) · Cellular and Molecular Life Sciences · doi:10.1007/bf02157378 · Cited by 203 · see citing works

Fatty Acid Hydroperoxide Lyase: A Plant Cytochrome P450 Enzyme Involved in Wound Healing and Pest Resistance

Noordermeer, M. A., Veldink, G. A., & Vliegenthart, J. F. G. (2001) · ChemBioChem · doi:10.1002/1439-7633(20010803)2:7/8 · Cited by 199 · see citing works

Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

McKenna, D. J., Repke, D. B., Lo, L., & Peroutka, S. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90001-8 · Cited by 195 · see citing works

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells

Szabo, A., Kovacs, A., Frecska, E., & Rajnavolgyi, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106533 · Cited by 191 · see citing works

Psychotomimetic N -Methylated Tryptamines: Formation in Brain in vivo and in vitro

Saavedra, J. M., & Axelrod, J. (1972) · Science · doi:10.1126/science.175.4028.1365 · Cited by 186 · see citing works

Enzymatic formation of psychotomimetic metabolites from normally occurring compounds

Axelrod, J. (1961) · Science · doi:10.1126/science.134.3475.343 · Cited by 184 · cited 1× · see citing works

Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation

Krähenmann, R., Pokorný, D., Vollenweider, L., Preller, K. H., Pokorny, T., Seifritz, E., & Vollenweider, F. X. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4610-0 · Cited by 177 · see citing works

The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke

Ruscher, K., Shamloo, M., Rickhag, M., Ladunga, I., Soriano, L., Gisselsson, L., Toresson, H., Ruslim-Litrus, L., Oksenberg, D., Urfer, R., et al. (2011) · Brain · doi:10.1093/brain/awq367 · Cited by 176 · see citing works

Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain

Soule, J. D., Messaoudi, E., & Bramham, C. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340600 · Cited by 172 · see citing works

Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1·GTP pathway

Tsai, S., Hayashi, T., Harvey, B. K., Wang, Y., Wu, W. W., Shen, R., Zhang, Y., Becker, K. G., Hoffer, B. J., & Su, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909089106 · Cited by 160 · see citing works

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter

Cozzi, N. V., Gopalakrishnan, A., Anderson, L. L., Feih, J. T., Shulgin, A. T., Daley, P. F., & Ruoho, A. E. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0308-8 · Cited by 144 · see citing works

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.

Barker, S. A., McIlhenny, E. H., & Strassman, R. (2012) · Drug Testing and Analysis · doi:10.1002/dta.422 · Cited by 142 · cited 6× · see citing works

Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine

Ott, J. (1999) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1999.10471741 · Cited by 140 · see citing works

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

SANTOS, R. G. D., Valle, M., Bouso, J. C., Nomdedeu, J. F., Rodrı́guez-Espinosa, J., McIlhenny, E. H., Barker, S. A., Barbanoj, M. J., & Riba, J. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823607f6 · Cited by 136 · see citing works

The current state of research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging

dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652578 · Cited by 125 · see citing works

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

Bogenschutz, M. P., & Pommy, J. M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1376 · Cited by 125 · see citing works

The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine

Gillin, J. C., Kaplan, J., Stillman, R. C., & Wyatt, R. J. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.2.203 · Cited by 123 · see citing works

The endogenous hallucinogen and trace amine N.N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells

Szabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00423 · Cited by 121 · see citing works

THE DISTRIBUTION AND PROPERTIES OF THE NONSPECIFIC N‐METHYLTRANSFERASE IN BRAIN

Saavedra, J. M., Coyle, J. T., & Axelrod, J. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb00035.x · Cited by 120 · see citing works

Treatment of Alcoholism Using Psychedelic Drugs: A Review of the Program of Research

Mangini, M. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399714 · Cited by 114 · see citing works

N,N-Dimethyltryptamine: An Endogenous Hallucinogen

Barker, S. A., Monti, J. A., & Christian, S. T. (1981) · International review of neurobiology · doi:10.1016/s0074-7742(08)60291-3 · Cited by 113 · see citing works

When the Endogenous Hallucinogenic Trace AmineN,N-Dimethyltryptamine Meets the Sigma-1 Receptor

Su, T., Hayashi, T., & Vaupel, D. B. (2009) · Science Signaling · doi:10.1126/scisignal.261pe12 · Cited by 110 · see citing works

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Frecska, E., Szabo, A., Winkelman, M. J., Luna, L. E., & McKenna, D. J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1024-y · Cited by 109 · cited 4× · see citing works

Classical hallucinogens and neuroimaging: A systematic review of human studies

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.026 · Cited by 107 · see citing works

A Dimethyltryptamine-Forming Enzyme in Human Blood

Wyatt, R. J., Saavedra, J. M., & Axelrod, J. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.7.754 · Cited by 102 · see citing works

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat

Pic‐Taylor, A., da Motta, L. G., de Morais, J. A., Melo, W., Santos, A. D. F. A., Campos, L. A., Mortari, M. R., von Zuben, M. V., & Caldas, E. D. (2015) · Behavioural Processes · doi:10.1016/j.beproc.2015.05.004 · Cited by 102 · see citing works

Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

Blough, B. E., Landavazo, A., Decker, A. M., Partilla, J. S., Baumann, M. H., & Rothman, R. B. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3557-7 · Cited by 101 · see citing works

Serotonergic psychedelics temporarily modify information transfer in humans.

Alonso, J. F., Romero, S., Mañanas, M. À., & Riba, J. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv039 · Cited by 101 · see citing works

Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study

Jordi Riba, A., McIlhenny, E. H., Bouso, J. C., & Barker, S. A. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1685 · Cited by 98 · see citing works

Metabolism and disposition of N,N‐dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Jordi Riba, A., McIlhenny, E. H., Valle, M., Bouso, J. C., & Barker, S. A. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1344 · Cited by 93 · see citing works

Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications

Kraehenmann, R. (2017) · Current Neuropharmacology · doi:10.2174/1573413713666170619092629 · Cited by 92 · see citing works

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113513851 · Cited by 89 · see citing works

Effect of some indolealkylamines on man

TURNER, W. J. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340130141020 · Cited by 88 · see citing works

Human Indolethylamine N-Methyltransferase: cDNA Cloning and Expression, Gene Cloning, and Chromosomal Localization

Thompson, M. A., Moon, E., Kim, U.-J., Xu, J., Siciliano, M. J., & Weinshilboum, R. M. (1999) · Genomics · doi:10.1006/geno.1999.5960 · Cited by 87 · see citing works

Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca

Yritia, M., Jordi Riba, A., Ortuño, J., Ramirez, A., Castillo, A., Alfaro, Y., de la Torre, R., & Barbanoj, M. J. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00397-5 · Cited by 85 · see citing works

Indole(ethyl)amine N -Methyltransferase in the Brain

Morgan, M. R. A., & Mandell, A. J. (1969) · Science · doi:10.1126/science.165.3892.492 · Cited by 83 · see citing works

Structure–activity relationships of serotonin 5‐HT2Aagonists

Nichols, D. E. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.42 · Cited by 82 · see citing works

Hallucinogen-induced relief of obsessions and compulsions

Moreno, F., & Delgado, P. L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.1037b · Cited by 81 · see citing works

Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N′-dimethyltryptamine forming enzyme, indole-N-methyl transferase

Mavlyutov, T. A., Epstein, M. L., Liu, P., Verbny, Y., Ziskind‐Conhaim, L., & Ruoho, A. E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.040 · Cited by 80 · see citing works

Hydroxylation and N-demethylation of N,N-dimethyltryptamine

Szára, S., & Axelrod, J. L. (1959) · Cellular and Molecular Life Sciences · doi:10.1007/bf02158111 · Cited by 74 · see citing works

Oxidative N-dealkylation

Fish, M. S., Johnson, N. M., Lawrence, E. P., & Horning, E. C. (1955) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(55)90150-5 · Cited by 74 · see citing works

Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors

Deliganis, A. V., Pierce, P. A., & Peroutka, S. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90178-8 · Cited by 73 · see citing works

Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT 2 signalling

Buchborn, T., Schröder, H., Höllt, V., & Grecksch, G. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114531666 · Cited by 72 · see citing works

Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users

Cakic, V., Potkonyak, J., & Marshall, A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.015 · Cited by 72 · see citing works

LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate.

Barker, S. A., Borjigin, J., Lomnicka, I., & Strassman, R. (2013) · Biomedical Chromatography · doi:10.1002/bmc.2981 · Cited by 72 · see citing works

Sigma receptor modulators: a patent review

Collina, S., Gaggeri, R., Marra, A., Bassi, A., Negrinotti, S., Negri, F., & Rossi, D. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.769522 · Cited by 71 · see citing works

Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates

Barker, S. A., Monti, J. A., & Christian, S. T. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90169-0 · Cited by 70 · see citing works

Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects

Kaplan, J., MANDEL, L. R., Stillman, R. C., Walker, R. W., VandenHeuvel, W. J. A., Gillin, J. C., & Wyatt, R. J. (1974) · Psychopharmacology · doi:10.1007/bf00421376 · Cited by 70 · see citing works

<i>N,N</i> -dimethyltryptamine and the pineal gland: Separating fact from myth

Nichols, D. E. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117736919 · Cited by 69 · see citing works

The Mode of Action Of 5-Hydroxytryptamine

Berridge, M. J. (1972) · Journal of Experimental Biology · doi:10.1242/jeb.56.2.311 · Cited by 67 · see citing works

Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons

Yang, Z.-J., Carter, E. L., Torbey, M., Martin, L. J., & Koehler, R. C. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.10.019 · Cited by 62 · see citing works

Induction of early growth response gene 2 expression in the forebrain of mice performing an attention-set-shifting task

DeSteno, D. A., & Schmauss, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.012 · Cited by 62 · see citing works

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

Daumann, J., Wagner, D. R., Heekeren, K., Neukirch, A., Thiel, C. M., & Gouzoulis‐Mayfrank, E. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103227 · Cited by 62 · see citing works

The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide

Rosenberg, D. E., Isbell, H., Miner, E. J., & Logan, C. R. (1964) · Psychopharmacology · doi:10.1007/bf00413244 · Cited by 61 · see citing works

Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor‐reactive effect of peripheral blood mononuclear cells

Tourino, M. C., de Oliveira, E. M., Bellé, L. P., Knebel, F. H., Albuquerque, R. C., Dörr, F. A., Okada, S. S., Migliorini, S., Soares, I. S., & Čampa, A. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2980 · Cited by 60 · see citing works

Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception.

Wallach, J. V. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.052 · Cited by 59 · see citing works

The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent

Christian, S. T., Harrison, R., Quayle, E., Pagel, J., & Monti, J. (1977) · Biochemical Medicine · doi:10.1016/0006-2944(77)90088-6 · Cited by 58 · cited 1× · see citing works

Methodology for determining major constituents of ayahuasca and their metabolites in blood

McIlhenny, E. H., Jordi Riba, A., Barbanoj, M. J., Strassman, R. J., & Barker, S. A. (2011) · Biomedical Chromatography · doi:10.1002/bmc.1657 · Cited by 57 · see citing works

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor

Halberstadt, A. L., Nichols, D. E., & Geyer, M. A. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2616-6 · Cited by 57 · see citing works

A SYNTHESIS OF THE METHYLTRYPTAMINES AND SOME DERIVATIVES

Manske, R. H. F. (1931) · Canadian Journal of Research · doi:10.1139/cjr31-097 · Cited by 57 · see citing works

Triptolines

Barchas, J. D. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760180100013 · Cited by 55 · see citing works

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Gallimore, A. R., & Strassman, R. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00211 · Cited by 53 · see citing works

Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis

Daumann, J., Heekeren, K., Neukirch, A., Thiel, C. M., Möller‐Hartmann, W., & Gouzoulis‐Mayfrank, E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1237-1 · Cited by 52 · see citing works

Rabbit Lung Indolethylamine N-Methyltransferase

Thompson, M. A., & Weinshilboum, R. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34502 · Cited by 51 · see citing works

Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice

Griesmaier, E., Posod, A., Gross, M. J., Neubauer, V., Wegleiter, K., Hermann, M., Urbanek, M., Keller, M., & Kiechl‐Kohlendorfer, U. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.030 · Cited by 50 · see citing works

Potentially hallucinogenic 5‐hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues

Kärkkäinen, J., Forsström, T., Tornaeus, J., Wähälä, K., Kiuru, P. S., Honkanen, A., Stenman, U., Turpeinen, U., & Hesso, A. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510510013604 · Cited by 50 · see citing works

Hallucinogenic N-Methylated Indolealkylamines in the Cerebrospinal Fluid of Psychiatric and Control Populations

Corbett, L., Christian, S. T., Morin, R. D., Benington, F., & Smythies, J. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.132.2.139 · Cited by 49 · see citing works

Cystathionine β-synthase deficiency causes infertility by impairing decidualization and gene expression networks in uterus implantation sites

Nuño-Ayala, M., Guillén, N., Arnal, C., Lou-Bonafonte, J. M., Martino, A. D., García-de-Jalón, J.-A., Gascón, S., Osaba, L., Osada, J., & Navarro, M. A. J. G. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00189.2010 · Cited by 44 · see citing works

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

Szabó, A., & Frecska, E. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.179041 · Cited by 44 · see citing works

A multidisciplinary overview of intoxicating enema rituals in the western hemisphere

Smet, P. A. G. M. D. (1983) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(83)90031-4 · Cited by 44 · see citing works

Human Hallucinogenic Drug Research in the United States: A Present-day Case History and Review of the Process

Strassman, R. J. (1991) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1991.10472572 · Cited by 43 · see citing works

Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry.

Smythies, Rd, M., & Brown, G. B. (1979) · PubMed · Cited by 43 · see citing works

Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogs

Glennon, R. A., Liebowitz, S. M., & Mack, E. C. (1978) · Journal of Medicinal Chemistry · doi:10.1021/jm00206a022 · Cited by 36 · see citing works

A proposed mechanism for the visions of dream sleep

Callaway, J. C. (1988) · Medical Hypotheses · doi:10.1016/0306-9877(88)90064-3 · Cited by 35 · see citing works

A Review of Recent Studies of the Biosynthesis and Excretion of Hallucinogens Formed by Methylation of Neurotransmitters or Related Substances

Rosengarten, H., & Friedhoff, A. J. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.90 · Cited by 35 · see citing works

DPT as an Adjunct in Psychotherapy of Alcoholics

Grof, S., Soskin, R. A., Richards, W. A., & Kurland, A. A. (2017) · International Pharmacopsychiatry · doi:10.1159/000467979 · Cited by 35 · see citing works

Gas-liquid chromatographic separation and identification of biologically important indolealkylamines from human cerebrospinal fluid

Christian, S. T., Benington, F., Morin, R. D., & Corbett, L. (1975) · Biochemical Medicine · doi:10.1016/0006-2944(75)90036-8 · Cited by 31 · see citing works

Synthesis of N pi-methylhistamine and N alpha-methylhistamine by purified rabbit lung indolethylamine N-methyltransferase.

Herman, K. S., Bowsher, R. R., & Henry, D. P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39030-0 · Cited by 29 · see citing works

Observations on the metabolism of the psychotomimetic indolealkylamines: Implications for future clinical studies

Sitaram, B. R., & McLeod, W. R. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90566-k · Cited by 29 · see citing works

On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis

Grammenos, D., & Barker, S. A. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1329-5 · Cited by 28 · see citing works

Comparison of the brain levels of N,N-dimethyltryptamine and α,α,β,β-tetradeutero-N,N-dimethyltryptamine following intraperitoneal injection

Barker, S. A., Beaton, J. M., Christian, S. T., Monti, J. A., & Morris, P. E. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90062-4 · Cited by 26 · see citing works

THE NATURE OF THE BINDING BETWEEN LSD AND A 5‐HT RECEPTOR: A POSSIBLE EXPLANATION FOR HALLUCINOGENIC ACTIVITY

Berridge, M. J., & Prince, W. (1974) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1974.tb09657.x · Cited by 26 · see citing works

The Dimethyltryptamine-Forming Enzyme in Blood Platelets: A Study in Monozygotic Twins Discordant for Schizophrenia

Wyatt, R. J., Saavedra, J. M., Belmaker, R. H., COHEN, S., & Pollin, W. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.12.1359 · Cited by 24 · see citing works

Ontogeny of N,N-Dimethyltryptamine and related indolealkylamine levels in neonatal rats

Beaton, J. M., & Morris, P. E. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90007-1 · Cited by 22 · see citing works

Behavioral effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with β-diethylaminoethyl-diphenylpropylacetate (SKF 525-A), iproniazid and chlorpromazine

Shah, N. S., & Hedden, M. P. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90070-9 · Cited by 22 · see citing works

Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases

Gomes, M. M., Coimbra, J. B., Clara, R. O., Dörr, F. A., Moreno, A. C. R., Chagas, J. R., Tufik, S., Pinto, E., Catalani, L. H., & Čampa, A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.035 · Cited by 22 · see citing works

DMT at fifty.

Szara, S. I. (2007) · PubMed · Cited by 22 · see citing works

In vivo metabolism of α,α,β,β-tetradeutero-n, N-dimethyltryptamine in rodent brain

Barker, S. A., Beaton, J. M., Christian, S. T., Monti, J. A., & Morris, P. E. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90404-0 · Cited by 21 · see citing works

Indolethylamine‐N‐methyltransferase in developing rabbit lung

Lin, R.-L., Sargeant, S., & Narasimhachari, N. (1974) · Developmental Psychobiology · doi:10.1002/dev.420070511 · Cited by 21 · see citing works

Inhibitory effect of 5-methoxy-N,N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine

Berge, O., Chacho, D., & Hole, K. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90253-4 · Cited by 20 · see citing works

Microwave‐accelerated synthesis of psychoactive deuterated N,N‐dialkylated‐[α,α,β,β‐d4]‐tryptamines

Brandt, S. D., Tirunarayanapuram, S. S., Freeman, S., Dempster, N. M., Barker, S. A., Daley, P. F., Cozzi, N. V., & Martins, C. P. B. (2008) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1557 · Cited by 19 · see citing works

Effects of iproniazid, chlorpromazine and methiothepin on DMT-induced changes in body temperature, pupillary dilatation, blood pressure and EEG in the rabbit.

Rh, M., Demetriou, S., & Ef, D. (1975) · PubMed · Cited by 15 · see citing works

Inhibition of Synaptosomal Neurotransmitter Uptake by Hallucinogens

Whipple, M. R., Reinecke, M. G., & Gage, F. H. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb08113.x · Cited by 14 · see citing works

Quantitative assay of theN-methylated metabolites of tryptamine and serotonin by gas chromatography mass spectrometry as applied to the determination of lung indoleethylamineN-methyltransferase activity

Räisänen, M., & Kärkkäinen, J. (1978) · Journal of Mass Spectrometry · doi:10.1002/bms.1200051010 · Cited by 14 · see citing works

A comparison of the behavioral effects of proteo- and deutero-N, N-dimethyltryptamine

Beaton, J. M., Barker, S. A., & Liu, W.-F. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90240-4 · Cited by 13 · see citing works

Evidence for dimethyltryptamine (DMT) as a naturally-occurring transmitter in mammalian brain.

St, C., Harrison, R. J., & Pagel, J. (1976) · PubMed · Cited by 9 · see citing works

Interaction of psychoactive drugs with the Mg+2 requiring ATPase associated with isolated synaptic vesicles.

Corbett, L., St, C., Monti, J. A., & McClain, L. D. (1975) · PubMed · Cited by 4 · see citing works

Evidence for the absence of amine-N-methylation and O-methylation in indolethylamines with methyltetrahydrofolic acid-dependent N-methyltransferase.

Rl, L., & Narasimhachari, N. (1974) · PubMed · Cited by 4 · see citing works

Inhibitor of indolethylamine N-methyltransferase in pineal extract.

Narasimhachari, N., Rl, L., & HIMWICH, H. E. (1974) · PubMed · Cited by 2 · see citing works

Survey of entity encounter experiences occasioned by inhaled N,N -dimethyltryptamine: Phenomenology, interpretation, and enduring effects

Davis, A. K., Clifton, J. M., Weaver, E. G., Hurwitz, E. S., Johnson, M. W., & Griffiths, R. R. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120916143 · Cited by 148 · see citing works

Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis

Yao, Y., Guo, D., Lu, T., Liu, F.-L., Huang, S., Diao, M.-Q., Li, S., Zhang, X.-J., Kosten, T. R., Shi, J., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115886 · Cited by 149 · see citing works

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo

Morales-Garcia, J. A., Calleja-Conde, J., Lopez-Moreno, J. A., Alonso-Gil, S., Sanz-SanCristobal, M., Riba, J., & Perez-Castillo, A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01011-0 · Cited by 138 · see citing works

Subacute effects of the psychedelic ayahuasca on the salience and default mode networks

Pasquini, L., Palhano-Fontes, F., & de Araújo, D. B. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120909409 · Cited by 115 · see citing works

Toxicokinetics and Toxicodynamics of Ayahuasca alkaloids N,N-dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: clinical and forensic impact

Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2020) · Pharmaceuticals · doi:10.3390/ph13110334 · Cited by 117 · see citing works

Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain

Dean, J. G., Liu, T., Huff, S., Sheler, B., Barker, S. A., Strassman, R. J., Wang, M. M., & Borjigin, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45812-w · Cited by 107 · see citing works

The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)

Reckweg, J. T., Uthaug, M. V., Szabó, A., Davis, A. K., Lancelotta, R., Mason, N. L., & Ramaekers, J. G. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15587 · Cited by 111 · see citing works

Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination.

Jiménez-Garrido, D. F., Gómez-Sousa, M., Ona, G., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-61169-x · Cited by 110 · see citing works

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

Kozłowska, U., Nichols, C. D., Wiatr, K., & Figiel, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15509 · Cited by 80 · see citing works

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment

Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works

Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study

van Oorsouw, K., Toennes, S. W., & Ramaekers, J. G. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06046-9 · Cited by 74 · see citing works

Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings

Pallavicini, C., Cavanna, F., Zamberlán, F., de la Fuente, L. A., Ilksoy, Y. A., Perl, Y. S., Arias, M., Romero, C., Carhart-Harris, R. L., Timmermann, C., et al. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120981384 · Cited by 83 · see citing works

Biosynthesis and synthetic biology of psychoactive natural products

Jamieson, C. S., Misa, J., Tang, Y., & Billingsley, J. M. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00065a · Cited by 71 · see citing works

Psychedelics as a novel approach to treating autoimmune conditions

Thompson, C., & Szabó, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.10.001 · Cited by 71 · see citing works

The morphological and functional characteristics of the pineal gland

Gheban, B., Rosca, I. A., & Crişan, M. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1235 · Cited by 68 · see citing works

Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms

Li, J., Sun, C., Cai, W., Li, J., Rosen, B. P., & Chen, J. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108396 · Cited by 68 · see citing works

Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience

Lawrence, D. W., Carhart-Harris, R. L., Griffiths, R. R., & Timmermann, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-11999-8 · Cited by 71 · see citing works

The Sentient Cell

Reber, A. S., Baluška, F., & Miller, W. B. (2023) · doi:10.1093/oso/9780198873211.001.0001 · Cited by 64 · see citing works

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT

Barker, S. A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06065-0 · Cited by 58 · see citing works

Pharmacokinetics of N,N-dimethyltryptamine in Humans

Good, M., Joel, Z., Benway, T. A., Routledge, C. A., Timmermann, C., Erritzøe, D., Weaver, R., Allen, G., Hughes, C., Topping, H., et al. (2023) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-023-00822-y · Cited by 67 · see citing works

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges

SANTOS, R. G. D., Bouso, J. C., Rocha, J. M., Rossi, G. N., & Hallak, J. E. C. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s300656 · Cited by 60 · see citing works

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers

Reckweg, J., Mason, N. L., van Leeuwen, C., Toennes, S. W., Terwey, T. H., & Ramaekers, J. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.760671 · Cited by 58 · see citing works

Exploring DMT: Endogenous role and therapeutic potential

Schimmelpfennig, J., & Jankowiak-Siuda, K. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110314 · Cited by 54 · see citing works

Psychedelics and virtual reality: parallels and applications

Aday, J. S., Davoli, C. C., & Bloesch, E. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320948356 · Cited by 47 · see citing works

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression

Falchi-Carvalho, M., Palhano-Fontes, F., Wießner, I., Barros, H., Bolcont, R., Laborde, S., Silva, S. R. B., Montanini, D., Barbosa, D. C., Teixeira, E., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02091-6 · Cited by 47 · see citing works

N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk

Cheng, D., Lei, Z., Chu, K., Lam, O. J. H., Chiang, C. Y., & Zhang, Z.-J. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01462-3 · Cited by 46 · see citing works

Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.

Cumming, P., Scheidegger, M., Dornbierer, D., Palner, M., Quednow, B. B., & Martin-Soelch, C. (2021) · Molecules · doi:10.3390/molecules26092451 · Cited by 43 · see citing works

Ayahuasca's therapeutic potential: What we know – and what not

Maia, L. O., Daldegan‐Bueno, D., Wießner, I., de Araújo, D. B., & Tófoli, L. F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.008 · Cited by 47 · see citing works

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology

Mastinu, A., Anyanwu, M., Carone, M., Abate, G., Bonini, S. A., Peron, G., Tirelli, E., Pucci, M., Ribaudo, G., Oselladore, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021329 · Cited by 49 · see citing works

Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain

Shahar, O., Botvinnik, A., Shwartz, A., Lerer, E., Golding, P., Buko, A., Hamid, E., Kahn, D., Guralnick, M., Blakolmer, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02477-w · Cited by 40 · see citing works

Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine benzoate) in healthy participants

Rucker, J., Roberts, C., Seynaeve, M., Young, A. H., Suttle, B., Yamamoto, T., Ermakova, A. O., Dunbar, F., & Wiegand, F. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241246857 · Cited by 41 · see citing works

N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine

James, E., Keppler, J., Robertshaw, T. L., & Sessa, B. (2022) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2835 · Cited by 43 · see citing works

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

Egger, K., Aicher, H., Cumming, P. D., & Scheidegger, M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05353-6 · Cited by 36 · see citing works

Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1–42-Injected, Wild-Type Mouse Model of AD

Borbély, E., Varga, V. É., Szögi, T., Schuster, I., Bozsó, Z., Penke, B., & Fülöp, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052514 · Cited by 34 · see citing works

Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate

Jiménez, J. H., & Bouso, J. C. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104054 · Cited by 37 · see citing works

The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study

Maia, L. O., Daldegan-Bueno, D., & Tófoli, L. F. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1854399 · Cited by 32 · see citing works

Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant

Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Biomolecules · doi:10.3390/biom12111618 · Cited by 33 · see citing works

Hypoxia Routes Tryptophan Homeostasis Towards Increased Tryptamine Production

Mohapatra, S. R., Sadik, A., Sharma, S. A., Poschet, G., Gegner, H. M., Lanz, T. V., Lucarelli, P., Klingmüller, U., Platten, M., Heiland, I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.590532 · Cited by 33 · see citing works

Adverse pharmacokinetic interactions between illicit substances and clinical drugs

Abbott, K. L., Flannery, P. C., Gill, K. S., Boothe, D. M., Dhanasekaran, M., Mani, S., & Pondugula, S. R. (2019) · Drug Metabolism Reviews · doi:10.1080/03602532.2019.1697283 · Cited by 33 · see citing works

Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression

Ramaekers, J. G., Reckweg, J. T., & Mason, N. L. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230890 · Cited by 32 · see citing works

The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity

Gupta, S., Bhatnagar, R. K., Gupta, D., Maharaj Kumari, K., & Chopra, A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06777-z · Cited by 30 · see citing works

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review

Więckiewicz, G., Stokłosa, I., Piegza, M. J., Gorczyca, P. W., & Pudło, R. (2021) · Pharmaceuticals · doi:10.3390/ph14080793 · Cited by 34 · see citing works

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial

Falchi-Carvalho, M., Wießner, I., Silva, S. R. B., Maia, L. O., Barros, H., Laborde, S., Arichelle, F., Tullman, S., Silva-Costa, N., Assunção, A., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.12.006 · Cited by 28 · see citing works

DARK Classics in Chemical Neuroscience: Gamma-Hydroxybutyrate (GHB)

Trombley, T. A., Capstick, R. A., & Lindsley, C. W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00336 · Cited by 29 · see citing works

Liquid chromatography–tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma

Luethi, D., Kolaczynska, K. E., Vogt, S. B., Ley, L., Erne, L., Liechti, M. E., & Duthaler, U. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123534 · Cited by 27 · see citing works

Peak-experience and the entheogenic use of cannabis in world religions

Ferrara, M. S. (2020) · Journal of Evolutionary Psychology · doi:10.1556/2054.2020.00122 · Cited by 26 · see citing works

Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?

Jensen, O., Rafehi, M., Gebauer, L., & Brockmöller, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.609811 · Cited by 25 · see citing works

Anadenanthera colubrina (Vell) Brenan: Ethnobotanical, phytochemical, pharmacological and toxicological aspects

Delices, M., Muller, J. D. A. I., Arunachalam, K., & Martins, D. T. D. O. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115745 · Cited by 25 · see citing works

Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity

Gianfratti, B., Tabach, R., Sakalem, M. E., Stessuk, T., Maia, L. O., & Carlini, E. A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114865 · Cited by 25 · see citing works

Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT 2A Receptor by a Light‐Controllable N , N ‐Dimethyltryptamine Derivative

Gerwe, H., He, F., Pottie, E., Stove, C. P., & Decker, M. W. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202203034 · Cited by 21 · see citing works

Sex-specificity of the C. elegans metabolome

Burkhardt, R. N., Artyukhin, A. B., Zucker-Aprison, E., Curtis, B. J., Fox, B. W., Ludewig, A. H., Palomino, D. F., Luo, J., Chaturbedi, A., Panda, O., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36040-y · Cited by 23 · see citing works

Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction

Glavonic, E., Mitić, M., & Adžić, M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25017 · Cited by 21 · see citing works

Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders

Shomrat, T., & Nesher, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00037 · Cited by 22 · see citing works

The current state of ayahuasca research in animal models: A systematic review

Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 20 · see citing works

Interpol review of controlled substances 2016–2019

Jones, N. S., & Comparin, J. H. (2020) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2020.01.019 · Cited by 18 · see citing works

Interaction of psychedelic tryptamine derivatives with a lipid bilayer

Zohairi, F., Khandelia, H., & Zanjani, A. A. H. (2023) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2023.105279 · Cited by 18 · see citing works

Phytochemistry and teratogenic potential of Mimosa tenuiflora (willd.) poir. (Fabaceae) in ruminants: A systematic review

Bezerra, J. J. L., Pinheiro, A. A. V., & Lucena, R. B. (2021) · Toxicon · doi:10.1016/j.toxicon.2021.03.010 · Cited by 18 · see citing works

Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats

Glynos, N. G., Carter, L., Lee, S. J., Kim, Y., Kennedy, R. T., Mashour, G. A., Wang, M. M., & Borjigin, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-27538-y · Cited by 17 · see citing works

Ayahuasca Pretreatment Prevents Sepsis-Induced Anxiety-Like Behavior, Neuroinflammation, and Oxidative Stress, and Increases Brain-Derived Neurotrophic Factor

de Camargo, R. W., Joaquim, L. D. S., Machado, R. S., Ramos, S. D. S., da Rosa, L. R., Júnior, L. R. D. N., Mathias, K., Maximiano, L., Strickert, Y. R., Nord, R., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04597-4 · Cited by 17 · see citing works

Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines

Grafinger, K. E., Wilke, A., König, S., & Weinmann, W. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2544 · Cited by 17 · see citing works

Neural network models for DMT-induced visual hallucinations

Schartner, M. M., & Timmermann, C. (2020) · Neuroscience of Consciousness · doi:10.1093/nc/niaa024 · Cited by 17 · see citing works

Neural and subjective effects of inhaled DMT in natural settingsPreprint

Pallavicini, C., Cavanna, F., Zamberlán, F., de la Fuente, L. A., Perl, Y. S., Arias, M., Romero, C., Carhart-Harris, R. L., Timmermann, C., & Tagliazucchi, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.19.258145 · Cited by 17 · see citing works

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

Vorobyeva, N. S., & Kozlova, A. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927984 · Cited by 19 · see citing works

A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine

Egger, K., Gudmundsen, F., Jessen, N. S., Baun, C., Poetzsch, S. N., Shalgunov, V., Herth, M. M., Quednow, B. B., Martin-Söelch, C., Dornbierer, D., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1140656 · Cited by 17 · see citing works

Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study

van Oorsouw, K. I. M., Uthaug, M. V., Mason, N. L., Broers, N. J., & Ramaekers, J. G. (2021) · Journal of Psychedelic Studies · doi:10.1556/2054.2021.00174 · Cited by 16 · see citing works

New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues

Schifano, F., Napoletano, F., Chiappini, S., Orsolini, L., Guirguis, A., Corkery, J., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. E. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00249-z · Cited by 16 · see citing works

Females in Psychedelic Research: A Perspective for Advancing Research and Practice

Cohen, Z. Z., & Blest‐Hopley, G. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00255 · Cited by 15 · see citing works

A Brief Review on the Potential of Psychedelics for Treating Alzheimer’s Disease and Related Depression

Pilozzi, A. R., Foster, S. L., Mischoulon, D., D, M. F. M., & Huang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512513 · Cited by 15 · see citing works

Therapeutic potential of natural psychoactive drugs for central nervous system disorders: A perspective from polypharmacology.

Oña, G., & Bouso, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191212103330 · Cited by 14 · see citing works

An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions

Askariyan, K., Joghataei, M. T., Dehghan, S., Nohesara, S., Rihipour, L., Mohammadi, M. H., & Ahmadirad, N. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111461 · Cited by 14 · see citing works

Key Characteristics and Development of Psychoceuticals: A Review

Cano, G. E. H., Dean, J., Abreu, S. P., Rodríguez, A. H., Abbasi, C., Hinson, M., & Lucke-Wold, B. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415777 · Cited by 14 · see citing works

Alkaloids: Their relevance in cancer treatment

Varela, C. L., Silva, F., Costa, G., & Cabral, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99873-4.00006-2 · Cited by 14 · see citing works

Psychedelic Therapy: A Primer for Primary Care Clinicians—N,N-Dimethyltryptamine and Ayahuasca

Shinozuka, K., Tabaac, B. J., Arenas, A., Beutler, B. D., Cherian, K. N., Evans, V. D., Fasano, C., & Muir, O. S. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001725 · Cited by 15 · see citing works

Synthesis and characterization of high‐purity N,N ‐dimethyltryptamine hemifumarate for human clinical trials

Cozzi, N. V., & Daley, P. F. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2889 · Cited by 14 · see citing works

Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca

Liu, M., Yang, H., Hu, J., Shen, B., Xiang, P., Qiang, H., Deng, H., Yu, Z., & Shi, Y. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110790 · Cited by 14 · see citing works

Advanced Praise for The Sentient Cell: The Cellular Foundations of Consciousness

Reber, A. S., Baluška, F., & Miller, W. B. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198873211.002.0008 · Cited by 14 · see citing works

Quantum chemical (QM:MM) investigation of the mechanism of enzymatic reaction of tryptamine and N , N -dimethyltryptamine with monoamine oxidase A

Kubicskó, K., & Farkas, Ö. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01118e · Cited by 12 · see citing works

The complete organellar genomes of the entheogenic plant Psychotria viridis (Rubiaceae), a main component of the ayahuasca brew

Varani, A. M., Silva, S. R., Lopes, S. S. D. S., Barbosa, J. B. F., de Oliveira, D. R., Corrêa, M. A., Moraes, A. P., Miranda, V. F. O., & Prosdocimi, F. (2022) · PeerJ · doi:10.7717/peerj.14114 · Cited by 11 · see citing works

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial

Mueller, M. J., Aicher, H., Dornbierer, D., Marten, L., Suay, D., Meling, D., Elsner, C., Wicki, I. A., Müller, J., Poetzsch, S. N., et al. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf001 · Cited by 10 · see citing works

Discovery and In Vitro Characterization of SPL028: Deuterated N , N -Dimethyltryptamine

Layzell, M., Rands, P., Good, M., Joel, Z., Cousins, R. P. C., Benway, T. A., James, E., & Routledge, C. A. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00143 · Cited by 9 · see citing works

The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness

Colosimo, F. A., Borsellino, P., Krider, R. I., Márquez, R., & Vida, T. A. (2024) · Psychoactives · doi:10.3390/psychoactives3010007 · Cited by 9 · see citing works

Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial

Wießner, I., Falchi-Carvalho, M., Laborde, S., Barros, H., Bolcont, R., Silva, S. R. B., Pantrigo, É. J., Medina, M., Arichelle, F., de Almeida, R. N., et al. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.06.002 · Cited by 9 · see citing works

Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans

Barman, R., Bora, P. K., Saikia, J., Konwar, P., Sarkar, A., Kemprai, P., Saikia, S. P., Haldar, S., Slater, R. J., & Banik, D. (2023) · Phytochemistry · doi:10.1016/j.phytochem.2023.113928 · Cited by 9 · see citing works

“Seat of the soul”? The structure and function of the pineal gland in women with alleged spirit possession—Results of two experimental studies

Bastos, M. A. V., Bastos, P. R. H. D. O., Paez, L. E. F. E., Souza, E. O., Bogo, D., Perdomo, R. T., Portella, R. B., Ozaki, J. G. O., Iandoli, D., & Lucchetti, G. (2020) · Brain and Behavior · doi:10.1002/brb3.1693 · Cited by 8 · see citing works

Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design

Miranda, P., Castro, A., Díaz, P., Minini, L., Ferraro, F., Paulsen, E., Faccio, R., & Pardo, H. (2024) · Polymers · doi:10.3390/polym16152148 · Cited by 6 · see citing works

The Key Role of Intracellular 5-HT2A Receptors: A Turning Point in Psychedelic Research?

Sapienza, J. (2023) · Psychoactives · doi:10.3390/psychoactives2040018 · Cited by 6 · see citing works

3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs

López‐Arnau, R., Camarasa, J., Carbó, M., Nadal‐Gratacós, N., Puigseslloses, P., Espinosa‐Velasco, M., Urquizu, E., Escubedo, E., & Pubill, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.990405 · Cited by 6 · see citing works

Preliminary evidence of links between ayahuasca use and the corpus callosum

Simonsson, O., Bouso, J. C., Kurth, F., de Araújo, D. B., Christian Gaser, B., Jordi Riba, A., & Eileen Luders, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1002455 · Cited by 6 · see citing works

Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the “God Molecule”

Al-Imam, A., Motyka, M. A., Hoffmann, B., Magowska, A. M., & Michalak, M. (2023) · Pharmaceuticals · doi:10.3390/ph16060831 · Cited by 6 · see citing works

Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators.

Myers, M. G., & Toal, C. B. (1995) · PubMed · Cited by 6 · see citing works

Defining 5-MeO-DMT in Historical and Cultural Contexts

Delgrasso, A. (2024) · World Futures · doi:10.1080/02604027.2024.2330255 · Cited by 5 · see citing works

The Biological Information Cycle

Reber, A. S., Baluška, F., & Miller, W. B. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198873211.003.0007 · Cited by 5 · see citing works

On the advances in machine learning and complex network measures to an EEG dataset from DMT experiments

Alves, C. L., Ciba, M., Toutain, T. G. L. D. O., Porto, J. A. M., de Sena, E. P., Thielemann, C., & Rodrigues, F. A. (2024) · Journal of Physics Complexity · doi:10.1088/2632-072x/ad1c68 · Cited by 4 · see citing works

Liquizald─Thermally Stable N-Nitrosamine Precursor for Diazomethane

Horvath-Gerber, F., Ohlig, D., Hii, K. K., Deadman, B. J., Attrill, R. P., & Hellgardt, K. (2024) · Organic Process Research & Development · doi:10.1021/acs.oprd.3c00456 · Cited by 5 · see citing works

1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Vilca-Melendez, S., Uthaug, M. V., & Griffin, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.742856 · Cited by 5 · see citing works

The immunomodulatory effects of psychedelics in Alzheimer’s disease-related dementia

Hosseini, A. M., Khaleghzadeh‐Ahangar, H., & Rahimi, A. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.062 · Cited by 4 · see citing works

Indole therapeutics: Latest FDA updates, ongoing trials, and future directions

Butt, N.-U.-H., & Baytaş, S. N. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104471 · Cited by 4 · see citing works

N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)

Lawrence, D. W., Battista, A. P. D., & Timmermann, C. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2230568 · Cited by 4 · see citing works

N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data

Barker, S. A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111259 · Cited by 4 · see citing works

Analysis of N,N‐dimethyltryptamine ( DMT ) and its metabolites using LC – MS / MS for forensic purposes

Gomonit, M. M., Swortwood, M. J., Truver, M. T., & Skillman, B. N. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70013 · Cited by 4 · see citing works

N,N-Dimethyltryptamine: An Endogenous Hallucinogen

Barker, S. A., Monti, J. A., & Christian, S. T. (1981) · International review of neurobiology · doi:10.1016/s0074-7742(08)60291-3 · Cited by 113 · see citing works

Endogenous Biosynthesis and Neural Correlates of N,N-dimethyltryptamine

Glynos, N. G. (2023) · Deep Blue (University of Michigan) · doi:10.7302/8314

Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine

Dean, J. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00232 · Cited by 37 · see citing works

A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine has Endogenous FunctionsPreprint

Solis, R. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.20823985

Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate

Jiménez, J. H., & Bouso, J. C. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104054 · Cited by 37 · see citing works